RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MAJEM M
Collezione AOU San Luigi di Orbassano

Items : 7

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial. in Lancet (London, England) / Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14.

2024
AOU San Luigi di Orbassano

Spicer JD; Garassino MC; Wakelee H; Liberman M; Kato T; Tsuboi M; Lee SH; Chen KN; Dooms C; Majem M; Eigendorff E; Martinengo GL; Bylicki O; Rodríguez-Abreu D; Chaft JE; Novello S; Yang J; Arunachalam A; Keller SM; Samkari A; Gao S;

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Oct;196:107921. doi: 10.1016/j.lungcan.2024.107921. Epub 2024 Aug 6.

2024
AOU San Luigi di Orbassano

Waterhouse DM; Rothschild S; Dooms C; Mennecier B; Bozorgmehr F; Majem M; van den Heuvel MH; Linardou H; Chul Cho B; Roberts-Thomson R; Tanaka K; Blais N; Schvartsman G; Holmskov Hansen K; Chmielewska I; Forster MD; Giannopoulou C; Stollenwerk B; Obiozor CC; Wang Y; Novello S;

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3.

2023
AOU San Luigi di Orbassano

Wakelee H; Liberman M; Kato T; Tsuboi M; Lee SH; Gao S; Chen KN; Dooms C; Majem M; Eigendorff E; Martinengo GL; Bylicki O; Rodríguez-Abreu D; Chaft JE; Novello S; Yang J; Keller SM; Samkari A; Spicer JD;

5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death Ligand 1-Positive Advanced Non-Small-Cell Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 May 25:S1556-0864(21)02172-9. doi: 10.1016/j.jtho.2021.05.001.

2021
AOU San Luigi di Orbassano

Herbst RS; Garon EB; Kim DW; Cho BC; Gervais R; Perez-Gracia JL; Han JY; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su WC; Samkari A; Jensen EH; Kobie J; Piperdi B; Baas P;

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jul;151:211-220. doi: 10.1016/j.ejca.2021.03.011. Epub 2021 May 19.

2021
AOU San Luigi di Orbassano

Paz-Ares L; Dingemans AM; Planchard D; Mariniello A; Rossoni C; Charrier M; Naigeon M; Majem M; Zalcman G; Plodkowski AJ; Girshman J; Sawan P; Hellmann MD; Novello S; Reale ML; Tabbò F; Bironzo P; Blanc-Durand F; Carnio S; Audigier-Valette C; Ponce S; Ruffinelli JC; Martin-Romano P; Nadal E; Park W; Rizvi H; Hendriks L; Saravia D; Auclin E; et alii...

FP13.01 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC in Journal of Thoracic Oncology

2021
AOU San Luigi di Orbassano

Herbst R; Garon E; Kim D; Cho BC; Gervais R; Perez-Gracia JL; Han J; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su W; Samkari A; Jensen EH; Piperdi B; Baas P;

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1?Positive, Advanced Non?Small-Cell Lung Cancer in the KEYNOTE-010 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1580-1590. doi: 10.1200/JCO.19.02446. Epub 2020 Feb 20.

2020
AOU San Luigi di Orbassano

Gubens MA; Su WC; Szalai Z; Novello S; Monnet I; Forster MD; Majem M; Arvis CD; Han JY; Perez-Gracia JL; Cho BC; Kim DW; Garon EB; Herbst RS; Ceresoli GL; Samkari A; Jensen EH; Lubiniecki GM; Baas P;